| Literature DB >> 3583616 |
L Jeromin, J Wiśniewski, M Rozniecki, Z Janiak, J Borkiewicz.
Abstract
A five-year follow-up is presented of 123 patients with recently diagnosed prostatic cancer, confirmed histopathologically and treated with fosfestrol and bromocriptine. The combined treatment has been shown to prevent most of the complications and side effects of therapy, thus it is considered to be worthy of recommendation.Entities:
Mesh：
Substances：
Year: 1987 PMID： 3583616 DOI： 10.1007/bf02549682
Source DB: PubMed Journal: Int Urol Nephrol ISSN： 0301-1623 Impact factor: 2.370